These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
624 related articles for article (PubMed ID: 16885745)
21. Mutant Nbs1 enhances cisplatin-induced DNA damage and cytotoxicity in head and neck cancer. Tran HM; Shi G; Li G; Carney JP; O'Malley B; Li D Otolaryngol Head Neck Surg; 2004 Oct; 131(4):477-84. PubMed ID: 15467621 [TBL] [Abstract][Full Text] [Related]
23. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec). Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359 [TBL] [Abstract][Full Text] [Related]
24. Chemotherapeutic alteration of β-catenin and c-kit expression by imatinib in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro. Schultz JD; Sommer JU; Hoedt S; Erben P; Hofheinz RD; Faber A; Thorn C; Hörmann K; Sauter A Oncol Rep; 2012 Jan; 27(1):270-80. PubMed ID: 21993766 [TBL] [Abstract][Full Text] [Related]
25. [In vitro killing effects of STI571 on esophageal carcinoma cell lines CE-48T and CE-81T]. Zhang PY; Li BJ; Su XD; Wen ZS; Zhao JM; Zhang LJ; Long H; Rong TH Ai Zheng; 2006 Apr; 25(4):456-60. PubMed ID: 16613680 [TBL] [Abstract][Full Text] [Related]
26. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin. Wang MB; Yip HT; Srivatsan ES Laryngoscope; 2001 Jun; 111(6):982-8. PubMed ID: 11404608 [TBL] [Abstract][Full Text] [Related]
27. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines. Xie XK; Yang DS; Ye ZM; Tao HM Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588 [TBL] [Abstract][Full Text] [Related]
28. Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium. Schmandt RE; Broaddus R; Lu KH; Shvartsman H; Thornton A; Malpica A; Sun C; Bodurka DC; Gershenson DM Cancer; 2003 Aug; 98(4):758-64. PubMed ID: 12910520 [TBL] [Abstract][Full Text] [Related]
29. Down-regulation of MMP-2 expression due to inhibition of receptor tyrosine kinases by imatinib and carboplatin in HNSCC. Schultz JD; Rotunno S; Erben P; Sommer JU; Anders C; Stern-Straeter J; Hofheinz RD; Hörmann K; Sauter A Oncol Rep; 2011 Apr; 25(4):1145-51. PubMed ID: 21249321 [TBL] [Abstract][Full Text] [Related]
30. Cisplatin resistance of the HNSCC cell line UT-SCC-26A can be overcome by stimulation of the EGF-receptor. Mandic R; Rodgarkia-Dara CJ; Krohn V; Wiegand S; Grénman R; Werner JA Anticancer Res; 2009 Apr; 29(4):1181-7. PubMed ID: 19414362 [TBL] [Abstract][Full Text] [Related]
31. Combination of vitamin K2 plus imatinib mesylate enhances induction of apoptosis in small cell lung cancer cell lines. Yokoyama T; Miyazawa K; Yoshida T; Ohyashiki K Int J Oncol; 2005 Jan; 26(1):33-40. PubMed ID: 15586222 [TBL] [Abstract][Full Text] [Related]
32. 7beta-hydroxycholesterol induces apoptosis and regulates cyclooxygenase 2 in head and neck squamous cell carcinoma. Heiduschka G; Erovic BM; Vormittag L; Skoda C; Martinek H; Brunner M; Ehrenberger K; Thurnher D Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):261-7. PubMed ID: 19289704 [TBL] [Abstract][Full Text] [Related]
33. Cytotoxic effects of the oncolytic herpes simplex virus HSV1716 alone and in combination with cisplatin in head and neck squamous cell carcinoma. Mace AT; Harrow SJ; Ganly I; Brown SM Acta Otolaryngol; 2007 Aug; 127(8):880-7. PubMed ID: 17763002 [TBL] [Abstract][Full Text] [Related]
34. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells. Johnson FM; Saigal B; Talpaz M; Donato NJ Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of cytotoxicity of cisplatin by cyclooxygenase-2 inhibitor nimesulide in head and neck cancer cell lines. Czembirek C; Eder-Czembirek C; Erovic BM; Turhani D; Selzer E; Thurnher D Oncol Rep; 2005 Dec; 14(6):1523-6. PubMed ID: 16273249 [TBL] [Abstract][Full Text] [Related]
36. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines. Crowe DL; Sinha UK Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195 [TBL] [Abstract][Full Text] [Related]
37. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line. Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826 [TBL] [Abstract][Full Text] [Related]
38. Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition. Te Kronnie G; Timeus F; Rinaldi A; Crescenzio N; Spinelli M; Rosolen A; Ricotti E; Basso G Int J Mol Med; 2004 Sep; 14(3):373-82. PubMed ID: 15289888 [TBL] [Abstract][Full Text] [Related]
39. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines. Avramis IA; Laug WE; Sausville EA; Avramis VI Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297 [TBL] [Abstract][Full Text] [Related]
40. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines. Xu SP; Sun GP; Shen YX; Peng WR; Wang H; Wei W Acta Pharmacol Sin; 2007 Jun; 28(6):869-78. PubMed ID: 17506946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]